D-0411-2025 Class II Ongoing

Recalled by RemedyRePack Inc. — Indiana, PA

FDA drug recall D-0411-2025 was initiated by RemedyRePack Inc. on Apr 22, 2025 and is designated Class II. Reason for recall: CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets. The recall status is ongoing. Affected quantity: 23 bottles/30 count- 690 capsules.

Recall details

Product Type
Drugs
Report Date
May 14, 2025
Initiation Date
Apr 22, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
23 bottles/30 count- 690 capsules

Product description

Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02

Reason for recall

CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.

Distribution pattern

Within U.S - PA, VA, FL.

Code information

Lot#: B3698036-033125, B3688703-032625, Exp.: 07/31/2026.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0411-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0411-2025. Report a data issue: hello@regdatalab.com.